Your browser doesn't support javascript.
loading
Limited benefits of thalidomide and dexamethasone maintenance after autologous stem cell transplantation in newly diagnosed multiple myeloma patients: a prospective phase II multi-center study in Korea.
Byun, Ja Min; Kim, Sang-A; Koh, Youngil; Shin, Dong-Yeop; Kwon, Ji Hyun; Kim, Jin Seok; Kim, Kihyun; Min, Chang-Ki; Eom, Hyeon-Seok; Lee, Je-Jung; Bang, Soo-Mee; Yoon, Sung-Soo.
Affiliation
  • Byun JM; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Kim SA; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea.
  • Koh Y; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Shin DY; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Kwon JH; Department of Internal Medicine, Chungbuk National University Hospital, Cheongju, Korea.
  • Kim JS; Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul, Korea.
  • Kim K; Division of Haematology-Oncology, Department of Medicine, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Min CK; Department of Hematology, Seoul St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Eom HS; Hematology-Oncology Clinic, National Cancer Center, Goyang, Korea.
  • Lee JJ; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun, Korea.
  • Bang SM; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
  • Yoon SS; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. Electronic address: ssysmc@snu.ac.kr.
Curr Probl Cancer ; 46(1): 100786, 2022 02.
Article in En | MEDLINE | ID: mdl-34481658
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Hematopoietic Stem Cell Transplantation / Multiple Myeloma Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Risk_factors_studies Aspects: Patient_preference Limits: Humans / Male / Middle aged Language: En Journal: Curr Probl Cancer Year: 2022 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Hematopoietic Stem Cell Transplantation / Multiple Myeloma Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Risk_factors_studies Aspects: Patient_preference Limits: Humans / Male / Middle aged Language: En Journal: Curr Probl Cancer Year: 2022 Document type: Article Country of publication: United States